Serum Assessment of Preterm Birth Outcomes Compared to Historical Controls: AVERT PRETERM TRIAL

NACompletedINTERVENTIONAL
Enrollment

1,873

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

March 16, 2020

Study Completion Date

June 1, 2024

Conditions
Preterm Birth
Interventions
OTHER

Screened Arm

Woman who are identified as high risk will be advised of potential interventions which will include support through care link(nurse education), cervical surveillance, consider vaginal progesterone, low dose aspirin if not already taking.

Trial Locations (1)

19718

Christiana Hospital, Newark

All Listed Sponsors
lead

Christiana Care Health Services

OTHER

NCT03151330 - Serum Assessment of Preterm Birth Outcomes Compared to Historical Controls: AVERT PRETERM TRIAL | Biotech Hunter | Biotech Hunter